Form 4: Molina Healthcare Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, reports acquisition and disposal of common stock related to performance stock units and restricted stock grants.
Summary
- On March 1, 2024, Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, engaged in several transactions involving the company's common stock.
- Barlow acquired 11,473 shares at $387.21 per share as settlement of performance stock units that vested at 170% achievement level based on the company's adjusted net income per share over three fiscal years.
- He also acquired 3,306 restricted stock shares under the 2019 Equity Incentive Plan at $387.21 per share.
- Additionally, 6,133 shares were disposed of to cover withholding taxes related to the vesting of performance stock units, and 2,205 shares were disposed of for withholding taxes related to the vesting of 4,137 shares.
- Following these transactions, Barlow beneficially owns 71,419 shares of Molina Healthcare common stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the vesting of performance stock units at a high achievement level, indicating strong company performance. The grant of restricted stock is also a positive sign. However, the disposal of shares for tax withholding tempers the overall sentiment.
Positives
- The vesting of performance stock units at 170% suggests strong performance by Molina Healthcare, exceeding initial targets.
- The grant of restricted stock indicates a continued investment in and incentivization of key executives like the Chief Legal Officer.
Negatives
- The disposal of shares to cover withholding taxes, while standard, reduces the executive's overall stake in the company.
Future Outlook
The 3,306 newly granted restricted stock shares will vest in one-third increments on March 1, 2025, March 1, 2026, and March 1, 2027; 2,636 shares shall vest on March 1, 2025; 1,461 shares shall vest on March 1, 2026.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, providing insights into management's alignment with shareholder interests and the company's performance.
Comparison to Industry Standards
- Executive compensation packages, including performance stock units and restricted stock grants, are standard practice among publicly traded healthcare companies like UnitedHealth Group, Anthem (Elevance Health), and Cigna.
- The vesting schedules and performance metrics used by Molina Healthcare are likely benchmarked against industry peers to attract and retain top talent.
- The level of stock ownership by executives is also a key metric compared to industry averages to assess alignment with shareholder value creation.
Stakeholder Impact
- Shareholders may view the vesting of performance stock units at a high achievement level as a positive indicator of company performance.
- Employees may be motivated by the company's success and the incentivization of key executives.
- The transactions have no direct impact on customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/01/2021 | Date of grant for performance stock units that vested based on performance over the three fiscal years of 2021, 2022, and 2023. |
| 03/01/2024 | Date of stock transactions: acquisition of shares from performance stock units and restricted stock, and disposal of shares for tax withholding. |
| 03/01/2025 | First vesting date for one-third of the 3,306 newly granted restricted stock shares, and vesting date for 2,636 additional shares. |
| 03/01/2026 | Second vesting date for one-third of the 3,306 newly granted restricted stock shares, and vesting date for 1,461 additional shares. |
| 03/01/2027 | Final vesting date for one-third of the 3,306 newly granted restricted stock shares. |
| 03/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.